MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/dth.15672

Медицинская библиотека · Dermatologic therapy · 2022

Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.

Moghadam Fateme Shirzad, Kianfar Nika, Dasdar Shayan, Samii Rana, Farimani Zeinab, Azar Pedram Molhem, Balighi Kamran, Abedini Robabeh, Soori Tahereh, Farid Ali Salehi, Mahmoudi Hamidreza, Daneshpazhooh Maryam

СтатьяПеревод в очереди

Аннотация

The ongoing COVID-19 pandemic has raised concerns regarding the outcome of this infection in patients with autoimmune bullous dermatoses (AIBDs) due to effect of drugs used to treat these disorders. This investigation was performed from the onset of the pandemic to June 1, 2021. Patients with AIBDs who contracted COVID-19 were evaluated. A generalized linear model was employed to find the predictors of severe COVID-19 among patients with AIBDs. Ninety-three patients with AIBDs with a mean age of 50.3 years were evaluated. The most COVID-19 related symptoms were tiredness (76.3%) myalgia (69%), and cough (63.4%). During follow-up, the rate of hospitalization and death were 45.2% and 4.3%, respectively. Previous comorbidities (β = 0.61) and mean prednisolone dosage above 10 mg/day in the last 3 months (β = 1.10) significantly increased COVID-19 severity. Also, vaccination against SARS-CoV-2 (β = -1.50) and each passing month from the last rituximab dose decreased severity (β = -0.02). Notably, 19.3% of the patients developed AIBD flare-ups following COVID-19 infection. Higher prednisone dose and the shorter interval from the last rituximab infusion were determinants of severe COVID-19. Physicians should assess the risk versus the benefits when prescribing the medications. Moreover, vaccination could successfully attenuate COVID-19 severity.

Для цитирования: Moghadam Fateme Shirzad, Kianfar Nika, Dasdar Shayan, Samii Rana, Farimani Zeinab, Azar Pedram Molhem, Balighi Kamran, Abedini Robabeh, Soori Tahereh, Farid Ali Salehi, Mahmoudi Hamidreza, Daneshpazhooh Maryam. Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.. Dermatologic therapy. 2022. DOI: 10.1111/dth.15672.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.